Join
Live feed
·
INSIDERFilingvia Quantisnow
Edesa Biotech Inc. logo

Director Sistilli Carlo was granted 19,000 shares, increasing direct ownership by 62% to 49,417 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EDSA· Edesa Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EDSA (Edesa Biotech Inc.) and more on Quantisnow.